Skip to main content

Telomir Pharmaceuticals, Inc.

corporate_fare Company Profile

Telomir Pharmaceuticals, Inc.

TELO·NASDAQ·Life Sciences·CIK 0001971532

Telomir Pharmaceuticals, Inc. is a preclinical-stage biotechnology company developing small-molecule therapeutics to target the biological causes of aging and age-related diseases, rather than just their symptoms. The company's research focuses on cellular processes linked to disease progression and functional decline, including issues with metal ions, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's primary investigational compound is Telomir-1 (Zn-Telomir), an orally administered small molecule. This compound is designed to adjust the balance of metals inside cells, specifically iron, copper, calcium, and zinc, through a controlled exchange mechanism, rather than broad chelation. Preclinical research has evaluated Telomir-1 in various in vitro and in vivo models to understand its biological activity, safety, and potential relevance across different disease pathways. The company has not yet conducted clinical trials in humans. Telomir Pharmaceuticals, Inc. entered into a Merger Agreement on November 20, 2025, amended on February 4, 2026, with TELI Pharmaceuticals, Inc., a private related party company incorporated in Delaware. Subject to shareholder approval, a wholly owned subsidiary of Telomir will merge with TELI, with TELI becoming a wholly owned subsidiary of Telomir. At the effective time of the merger, each outstanding share of TELI Common Stock, $0.0001 par value per share, will be converted into Telomir Common Stock based on the exchange ratio for the merger.

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 28 items for TELO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for TELO spans 10-Q, S-3, 8-K.

Recent high-impact activity:

  • Telomir Q3 Loss Narrows to $0.7M; Cash Runway Extended Into Q4 2027
  • Telomir Registers Resale of 5.29M PIPE Shares, Making October Overhang Tradable
  • Telomir Raises $5.6M in PIPE at $1.16/Share; DeJoria Adds $1M
  • Telomir Raises $5.6M PIPE at $1.16/Share; DeJoria Adds $1M to Fund TNBC Trial
  • Telomir Flags Going Concern Doubt, Cash Only Through Q1 2027

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$10.41M
Diluted EPS
-$0.33
Op. Cash Flow
-$3.69M
Cash & Equivalents
$7.29M
Debt / Equity
0.00×
Shares Outstanding
34.38M sh
Source: 10-K · filed 2026-03-17 · accession 0001493152-26-010625

Short Interest & Short Volume

11.90 days to cover

FINRA reported short interest of 750,539 shares in TELO as of the October 30, 2026 settlement, a 2.5% decrease from the prior period — about 11.9 days to cover at its recent average daily volume. On November 20, 2026, 47.2% of TELO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)750,539 shares as of October 30, 2026
Change vs prior period▼ 2.5%
Days to cover11.90 at avg daily volume of 63,071
Daily short volume (FINRA facilities)47.2% of 122,356 shares on November 20, 2026
5-day average short volume51.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for TELO, detected from its recent SEC filings.

1 shelf registration

Resale Registration for PIPE Shares · Overhang Is About 7% of Shares

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with T →
$0.373 +2.47% today
52-week range · as of 2026-11-06 $0.373 – $1.58
Market cap
$26.82M
Volume
255.9K (1.8× avg)
3-mo avg 146.1K
Live data · 2026-11-21 11:56 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TELO - Latest Insights

TELO
Nov 06, 2026, 4:41 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.740
Real-time Price: $0.373 info
Change: -$0.367 (-50%) info
Market Cap: $26.818M info
TELO
Oct 27, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.02
Real-time Price: $0.373 info
Change: -$0.647 (-63%) info
Market Cap: $26.818M info
TELO
Oct 06, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $0.373 info
Change: -$0.867 (-70%) info
Market Cap: $26.818M info
TELO
Oct 06, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.28
Real-time Price: $0.373 info
Change: -$0.907 (-71%) info
Market Cap: $26.818M info
TELO
Aug 13, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.05
Real-time Price: $0.373 info
Change: -$0.677 (-64%) info
Market Cap: $26.818M info
TELO
Aug 10, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $0.373 info
Change: -$0.827 (-69%) info
Market Cap: $26.818M info
TELO
Aug 10, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $0.373 info
Change: -$0.817 (-69%) info
Market Cap: $26.818M info
TELO
Jun 15, 2026, 8:03 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.27
Real-time Price: $0.373 info
Change: -$0.8925 (-71%) info
Market Cap: $26.818M info
TELO
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.25
Real-time Price: $0.373 info
Change: -$0.877 (-70%) info
Market Cap: $26.818M info
TELO
Jun 08, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.28
Real-time Price: $0.373 info
Change: -$0.907 (-71%) info
Market Cap: $26.818M info
TELO
May 20, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.28
Real-time Price: $0.373 info
Change: -$0.907 (-71%) info
Market Cap: $26.818M info
TELO
May 14, 2026, 3:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.28
Real-time Price: $0.373 info
Change: -$0.902 (-71%) info
Market Cap: $26.818M info
TELO
Apr 30, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $0.373 info
Change: -$1.12 (-75%) info
Market Cap: $26.818M info
TELO
Apr 30, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $0.373 info
Change: -$1.12 (-75%) info
Market Cap: $26.818M info
TELO
Apr 24, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.38
Real-time Price: $0.373 info
Change: -$1.01 (-73%) info
Market Cap: $26.818M info
TELO
Apr 24, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $1.38
Real-time Price: $0.373 info
Change: -$1.01 (-73%) info
Market Cap: $26.818M info
TELO
Mar 31, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.18
Real-time Price: $0.373 info
Change: -$0.806 (-68%) info
Market Cap: $26.818M info
TELO
Mar 31, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.14
Real-time Price: $0.373 info
Change: -$0.767 (-67%) info
Market Cap: $26.818M info
TELO
Mar 27, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $0.373 info
Change: -$0.837 (-69%) info
Market Cap: $26.818M info
TELO
Mar 27, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $0.373 info
Change: -$0.837 (-69%) info
Market Cap: $26.818M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets